Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of substance for detecting SPARC (Satraplatin and Prednisone Against Refractory Cancer) protein in blood serum to preparation of kit for screening hepatocellular carcinoma

A technology for hepatocellular carcinoma and serum, applied in the biological field, can solve the problems of opposite expression levels and complexities

Active Publication Date: 2017-03-15
BEIJING PROTEOME RES CENT +1
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the relationship between the expression levels of each protein in peripheral blood and tissues is very complicated, and its expression level in peripheral blood cannot be simply deduced from the expression level in tissues, and sometimes the expression levels of the two are completely opposite

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of substance for detecting SPARC (Satraplatin and Prednisone Against Refractory Cancer) protein in blood serum to preparation of kit for screening hepatocellular carcinoma
  • Application of substance for detecting SPARC (Satraplatin and Prednisone Against Refractory Cancer) protein in blood serum to preparation of kit for screening hepatocellular carcinoma
  • Application of substance for detecting SPARC (Satraplatin and Prednisone Against Refractory Cancer) protein in blood serum to preparation of kit for screening hepatocellular carcinoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Embodiment 1, the relationship between SPARC protein in serum and HCC patient

[0042] 1. Experimental materials

[0043] Serum samples were obtained from:

[0044] Normal group: 30 cases of normal people (N);

[0045]LC patient group: 35 patients with liver cirrhosis (not transformed into hepatocellular carcinoma, LC) with HBV chronic infection background;

[0046] HCC patient group: 50 patients with hepatocellular carcinoma (HCC) with HBV chronic infection background (23 of them were APF negative).

[0047] Among them, the serum samples of normal people were from healthy persons; the serum samples of patients with liver cirrhosis and patients with hepatocellular carcinoma were clinically confirmed patients.

[0048] 2. Relationship between SPARC protein in serum and HCC patients

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention discloses new application of a substance for detecting the concentration of an SPARC (Satraplatin and Prednisone Against Refractory Cancer) protein. The new application provided by the invention is application of a substance for detecting SPARC protein concentration to preparation of a product for screening or helping to screen the hepatocellular carcinoma. An experiment proves that the SPARC protein can be used as a tumor marker of the hepatocellular carcinoma; screening is carried out under the condition of taking normal persons as screening targets, the sensitivity of judging HCC patients is 82%, the specificity is 93% and the AUC (Area Under roc Curve) is 0.89; screening is carried out by taking LC (Liver Cirrhosis) patients as screening targets, the sensitivity of judging the HCC patients is 62%, the specificity is 86% and the AUC is 0.73; the SPARC protein can be used for diagnosing AFP (Alpha-fetoprotein) negative hepatocellular carcinoma; and the SPARC protein can also be combined with AFP to be used for screening or helping to diagnose the HCC from the normal persons or the LC patients.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to the application of a substance for detecting SPARC protein in serum in the preparation of a kit for screening hepatocellular carcinoma. Background technique [0002] Hepatocellular carcinoma (hepatocellular carcinoma, HCC) is one of the common malignant tumors with high morbidity and mortality. About 650,000 people die from HCC every year, and the incidence rate tends to increase. The disease occurs mainly in Southeast Asia, and more than 50% of it occurs in China. The occurrence of hepatocellular carcinoma is a multi-factor and multi-stage process. Chronic infection of hepatitis B virus (HBV) is an important high-risk factor. Patients with liver cirrhosis (LC) with hepatitis B background It is a high-risk group that may develop liver cancer. At present, the 5-year survival rate of hepatocellular carcinoma is poor. Early screening of hepatocellular carcinoma, especially screening o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/574
CPCG01N33/56966G01N33/57438G01N33/57476G01N33/57488
Inventor 贺福初孙薇张剑孙龙钦邢宝才牟劲松赵晓航
Owner BEIJING PROTEOME RES CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com